For example: Apple Inc, UTIL, Aluminum
PDL BioPharma Inc
NASDAQ:PDLI
Market Close 11/27
2.59 USD +0.03 (+1.17%)
OPEN:
2.56
DAY RANGE:
2.54 - 2.62
PE:
10.47
PB:
0.58
PS:
2.87
WTD % 5.71
MTD % 20.47
QTD % -17.78
YTD % -20.18
* Updated at market close
PDL BioPharma Inc (NASDAQ:PDLI) opened on Nov 27, 2020 at 2.56 USD and increased by 1.17%. The intraday price range was 2.54 - 2.62 USD and eventually ended the session at 2.59 USD. The stock trade volume was 1.17 M shares. The company's 52-week range is 2.09 - 3.86 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 301.86 M
Outstanding Stock 145.98 M
Dividend 0.00
Dividend Yield 0.00
EPS 0.30
YTD Change -20.18%
52 Week's Range 2.09 - 3.86
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning 10.47
Price/Book Value 0.58
Price/Sales 2.87
ROA -
ROE -
Debt/Equity 0.34
Company Self Description
PDL BioPharma, Inc. acquires and manages companies, products, royalty agreements, and debt facilities in the biotechnology, pharmaceutical, and medical device industries in the United States, Europe, and internationally. The company operates in three segments: Income Generating Assets, Pharmaceutical, and Medical Devices. It was founded in 1986 and is headquartered in Incline Village, Nevada, United States.
Business Information
PDL BioPharma Inc
Sector Health Care
Industry Biotechnology
Exchange NASDAQ
Top Competitors (Market Close Nov 27, 2020)
  PDLI ASLN CASI RIOT
Daily Change (%) 1.17 0.53 -6.20 -11.72
WTD (%) 5.71 7.43 9.50 4.25
MTD (%) 20.47 13.26 2.98 91.13
QTD (%) -17.78 -1.05 58.17 131.48
YTD (%) -20.18 -7.39 -21.68 458.04
52-Week Change (%) -14.80 -18.97 -27.11 362.96
Stock Performance (Market Close Nov 27, 2020)
  PDLI ASLN CASI RIOT
Daily Change (%) 1.17 0.53 -6.20 -11.72
WTD (%) 5.71 7.43 9.50 4.25
MTD (%) 20.47 13.26 2.98 91.13
QTD (%) -17.78 -1.05 58.17 131.48
YTD (%) -20.18 -7.39 -21.68 458.04
52-Week Change (%) -14.80 -18.97 -27.11 362.96
Key Fundamentals (Market Close Nov 27, 2020)
  PDLI ASLN CASI RIOT
Market Cap 301.86 M 301.27 M 299.94 M 296.26 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin 34.10% 0.00 0.00 -408.20%
P/E Ratio 10.47 -12.86 -7.11 -1.40
Price to Sales Ratio 2.87 0 0 6.32
Price to Book Ratio 0.58 19.71 3.44 3.78
Enterprise Value to EBITDA -5.20 -13.57 -10.81 -0.41
ROA - -81.00% -34.50% -151.00%
ROE - -127.60% -39.90% -315.10%
Debt/Equity 0.34 0.73 0.04 1.62
Asset Turnover Ratio 0.14 0 0 0.37
Current Ratio 9.86 3.64 23.89 0.35
Dividend Yield 0.00 - 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 198.11 M 320.06 M 244.30 M 590.45 M
Cost Of Revenue 48.46 M 30.54 M 4.07 M 0.00
Gross Profit 149.65 M 289.52 M 240.24 M 590.45 M
Selling General & Administrative Expenses 65.51 M 70.71 M 44.15 M 36.09 M
Research & Development 0.00 0.00 0.00 0.00
Operating Income -50.59 M 193.78 M 129.40 M 550.38 M
Net Income -68.86 M 110.75 M 63.61 M 332.80 M
EPS -0.47 0.71 0.39 2.04
Diluted EPS -0.47 0.71 0.39 2.03
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue -22.53 M 38.91 M 45.12 M 67.90 M
Cost Of Revenue 12.35 M 12.81 M 11.44 M 11.93 M
Gross Profit -34.87 M 26.10 M 33.68 M 55.97 M
Selling General & Administrative Expenses 13.44 M 14.06 M 9.60 M 17.35 M
Research & Development 0.00 0.00 0.00 0.00
Operating Income -49.91 M 10.47 M 33.50 M 36.74 M
Net Income -4.42 M 6.68 M 16.28 M 25.56 M
EPS -0.04 0.05 0.11 0.18
Diluted EPS -0.04 0.05 0.11 0.18
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 517.22 M 640.44 M 398.03 M 282.71 M
Cash & Cash Equivalents 394.59 M 527.27 M 147.15 M 218.88 M
Total Assets 963.74 M 1.24 B 1.22 B 1.01 B
Total Current Liabilities 52.47 M 193.11 M 130.32 M 36.74 M
Total Liabilities 233.96 M 397.23 M 459.96 M 316.25 M
Shareholder's Equity 729.78 M 845.89 M 751.14 M 695.95 M
Outstanding Stock 145.98 M 154.34 M 165.54 M 163.58 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 399.70 M 477.55 M 517.22 M 507.75 M
Cash & Cash Equivalents 284.94 M 366.32 M 394.59 M 400.98 M
Total Assets 890.46 M 923.53 M 963.74 M 984.43 M
Total Current Liabilities 38.34 M 43.32 M 52.47 M 46.67 M
Total Liabilities 225.04 M 229.75 M 233.96 M 245.04 M
Shareholder's Equity 665.23 M 693.28 M 729.78 M 739.39 M
Outstanding Stock 120.65 M 128.11 M 145.98 M 145.40 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations -13.43 M 40.62 M 101.72 M 301.47 M
Capital Expenditures 53.45 M 105.96 M 13.06 M -71.60 M
Net Cash Flow from Investing Activities 56.70 M 458.89 M -144.51 M -79.65 M
Net Cash Flow from Financial Activities -175.96 M -119.40 M -28.94 M -294.31 M
Free Cash Flow 40.02 M 146.58 M 114.78 M 229.86 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations -12.69 M 40.62 M 101.72 M 301.47 M
Capital Expenditures 18.29 M 12.58 M 1.04 M 18.33 M
Net Cash Flow from Investing Activities -41.72 M 12.58 M 20.18 M -1.67 M
Net Cash Flow from Financial Activities -26.98 M -45.36 M -24.51 M -1.40 M
Free Cash Flow 5.60 M 17.09 M -1.03 M 26.73 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio 10.47 -8.86 -6.17 -6.26
Price to Sales Ratio 2.87 2.41 2.13 1.70
Price to Book Ratio 0.58 0.50 0.47 0.83
Enterprise Value to EBIT -3.00 1.00 4.00 1.00
Enterprise Value to EBITDA -5.20 0.67 3.43 1.23
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - -6.90% 8.80%
ROE - - -9.10% 13.60%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 464.75 M 447.33 M 267.72 M 245.97 M
Current Ratio 9.86 3.32 3.05 7.70
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 0.34 0.47 0.61 0.45
Asset Turnover Ratio - - 0.20 0.26
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.